Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma-Reference-Cited by-同舟云学术

Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma

Published:2015-11-10 Issue:1 Volume:6 Page:
ISSN:2041-1723
Container-title:Nature Communications
language:en
Short-container-title:Nat Commun

Author:

De Mattos-Arruda Leticia,Mayor Regina,Ng Charlotte K. Y.,Weigelt Britta,Martínez-Ricarte Francisco,Torrejon Davis,Oliveira Mafalda,Arias Alexandra,Raventos Carolina,Tang Jiabin,Guerini-Rocco Elena,Martínez-Sáez Elena,Lois Sergio,Marín Oscar,de la Cruz Xavier,Piscuoglio Salvatore^ORCID,Towers Russel,Vivancos Ana,Peg Vicente^ORCID,Ramon y Cajal Santiago,Carles Joan,Rodon Jordi,González-Cao María,Tabernero Josep,Felip Enriqueta,Sahuquillo Joan,Berger Michael F.,Cortes Javier,Reis-Filho Jorge S.,Seoane Joan

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry

Link

http://www.nature.com/articles/ncomms9839.pdf

Reference26 articles.

1. Gerlinger, M. et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N. Engl. J. Med. 366, 883–892 (2012).

2. Sottoriva, A. et al. Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics. Proc. Natl Acad. Sci. USA 110, 4009–4014 (2013).

3. Omuro, A. & DeAngelis, L. M. Glioblastoma and other malignant gliomas: a clinical review. JAMA 310, 1842–1850 (2013).

4. Murtaza, M. et al. Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA. Nature 497, 108–112 (2013).

5. Dawson, S. J. et al. Analysis of circulating tumor DNA to monitor metastatic breast cancer. N. Engl. J. Med. 368, 1199–1209 (2013).

Cited by 630 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proteomic profiling of cerebrospinal fluid reveals TKT as a potential biomarker for medulloblastoma;Scientific Reports;2024-09-10

2. The DEBBRAH trial: Trastuzumab deruxtecan in HER2-positive and HER2-low breast cancer patients with leptomeningeal carcinomatosis;Med;2024-09

3. Monitoring pediatric CNS non‐germinomatous germ cell tumors via cerebrospinal fluid circulating tumor DNA;Pediatric Blood & Cancer;2024-08-27

4. Tyrosine kinase inhibitors in the treatment of leptomeningeal carcinomatosis;Cell Biology International;2024-08-13

5. The omics technologies and liquid biopsies: Advantages, limitations, applications;Medicine in Omics;2024-08